Formerly Halyard Health, Inc.
Spin-offSpun off from Kimberly-ClarkKMBNasdaq
The two companies
Open either company's hub for its full SEC financials, ratios, ownership, filings, and every other event it's been part of.
- Sector
- Healthcare
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- Exchange
- NYSE
- State of incorporation
- DE
- Record date
- October 23, 2014
- Distribution date
- October 31, 2014
- Ratio
- 1:8
- Parent sector
- Converted Paper & Paperboard Prods (No Contaners/Boxes)
- Form
- 10-12B/A
- Filed
- October 15, 2014
Financials — parent vs spin-off
SEC XBRL · latest year- Revenue
- $4.05B
- Operating income
- $2.35B
- Net income
- $567M
- Total assets
- $17.10B
- Equity
- $1.50B
- Revenue
- $701M
- Operating income
- −$62M
- Net income
- −$73M
- Total assets
- $1.07B
- Equity
- $778M
Latest reported figures from each company's own SEC filings — the parent after the separation and the spin-off as a standalone. Full multi-year history on each company hub.
Spin-off signals
score 4/8 favorable · factors, not advice- Focus-increasingYes — Materials → Healthcare
Spin-offs into a different sector than the parent (pure-plays) have historically outperformed diversifying ones.
- Size vs parent (revenue)~17% of parent
Smaller spin-offs draw more forced selling from holders who can't keep them — the classic mispricing edge.
- Leverage (liabilities/assets)28%
A heavy debt load loaded onto the spin-off is a known risk; a clean balance sheet is favorable.
- Return on capital employed-6.8%
EBIT ÷ capital employed — the quality metric the spin-off scorecard research weighs most.
- Operating margin-8.8%
Profitability of the standalone business, from its own SEC filings.
- Tax-basis reportNone found
A Form 8937 (basis allocation) accompanies tax-free §355 spin-offs — favorable for taxable holders.
- Insider buying (post-spin)1 open-market buy
Officers/directors buying their own newly independent shares (Form 4) has historically preceded outperformance.
- Time since spin-off11.6 years
Studies find the spin-off return premium concentrates in roughly the first one to three years.
Factors the spin-off research literature (Greenblatt; Cusatis-Miles-Woolridge; Desai-Jain) associates with outcomes — computed from this company's own SEC filings, shown as factors, not a recommendation. The premium is debated and not guaranteed. How we compute these ↗
Filings & documents
Every entry traces to SEC EDGAR. The Information Statement is the primary source; the links below open the full filing and each company's complete filing history.